The overall status in rheumatoid arthritis (OSRA) measure - Further evidence to support its use in clinical practice

Rheumatology

Volumn 46, Issue 5, 2007, Pages 849-855

  Harrison, M J ^a   Hassell, A ^b   Dawes, P T ^b   Scott, D L ^c   Knight, S M ^d   Davis, M J ^e   Mulherin, D ^f   Symmons, Deorah P M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^e ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^f Mid Staffordshire General Hospitals NHS Trust   (United Kingdom)

Author keywords

Health status; Quality of life; Randomized controlled trial; Rheumatoid arthritis; Socioeconomic factors; Validity (epidemiology)

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTRUCT VALIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL STATUS IN RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SELF REPORT; SOCIAL ISOLATION; SYMPTOMATOLOGY; VALIDATION STUDY; DISEASE COURSE; EPIDEMIOLOGY; HEALTH SURVEY; HOSPITALIZATION; MIDDLE AGED; QUALITY OF LIFE; SOCIOECONOMICS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENT;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 34347267331     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel445     Document Type: Article

References (33)

1. Symmons DP, Hassell AB, Gunatillaka KA, Jones PJ, Schollum J, Dawes PT. Development and preliminary assessment of a simple measure of overall status in reumatoid arthritis (OSRA) for routine clinical use. Q J Med 1995;88:429-37.
2. Apgar V. Proposal for a new method of evaluation of newborn infants. Anesth Analg 1953;32:260-7.
3. Birrell FN, Hassell AB, Jones PW, Dawes PT. Why not use OSRA? A comparison of overall status in rheumatoid arthritis (RA) with ACR core set and other indices of disease activity in RA. J Rheumatol 1998;25:1709-15.
4. Williamson L, Mowat A, Burge P. Screening for extensor tendon rupture in rheumatoid arthritis. Rhaumatology 2001;40:420-3.
5. Symmons DPM, Tricker K, Roberts C, Davies L, Dawes P, Scott DL. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technology Assessment, 2004.
6. Symmons D, Tricker K, Harrison M et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs - results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology 2006;45:558-65.
7. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9.
8. OMERACT, Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Proceedings. Maastricht, The Netherlands, April 29-May 3. 1992. J Rheumatol 1993;20:527-91.
9. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30.473-83.
10. The EuroQol GroupEuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16;199-208.
11. Ware JE, Jr, Kosinski MA, Keller SD. SF-36 physical and mental health summary scales: A user's manual. Boston, MA; Health Assessment Lab, New England Medical Center, 1994.
12. Tuttleman M, Pillemer SR, Tilley BC et al. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. J Rhaumatol 1997;24:1910-5.
13. Larsen A, Dale K, Eek M. Radiographic evaluation of rhoumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
14. Townsend P, Phillimore P, Beattie A. Health and deprivation: Inequality and the North. Kent: Croom Helm Ltd, 1988.
15. Census Dissemination Unit. Townsend scores for England & Wales. http://census.ac.uk/edu/Datasets/1991_Census_datasets/ Area_Stats/Derived_data/Deprivation_scores/ Pre_calculated_deprivation_scores.htm#4, 2004.
16. Dolan SA, Jarman B, Bajekal M, Davies PM, Hart D. Measuring disadvantage: Changes in the underprivileged area, Townsend, and Carstairs scores 1981-91. J Epidemiol Community Health 1995;49 (Suppl 2):S30-3.
17. Morris R, Carstairs V. Which deprivation - a comparison of selected deprivation indexes. J Public Health Med 1991;13:318-26.
18. Harrison MJ, Tricker KJ, Davies L et al. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rhaumatol 2005;32:2330-6.
19. Pincus T, Callahan LF. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 1985;38:973-84.
20. Maiden N, Capell HA, Madhok R, Hampson R, Thomson EA. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis 1999;58:525-9.
21. Callahan LF, Pincus T. Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 1988;31:1346-57.
22. ERAS Study Group. Socioeconomic deprivation and rheumatoid disease: What lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study. Ann Rheum Dis 2000;59:794-9.
23. Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, Van Den Bos GA. Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum 2003;49:567-73.
24. McEntegart A, Morrison E, Capell HA et al. Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:410-3.
25. Marra C, Lynd LD, Esdaile JM, Kopec JA, Anis AH. The impact of low income on self-reported health outcomes in patients with rheumatoid arthritis within a pubicly funded health-care environment. Rhoumatology 2004;43:1390-7.
26. Bowling A. Research methods in health: Investigating health and health services. Buckingham: Open University Press, 2002.
27. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-92.
28. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PMM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003:12:349-62.
29. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
30. Kazis LE, Anderson JJ, Meenan AF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-89.
31. Cohen J. Statistical power analysis for the behavioural sciences. New Jersey: Lawrence Earlbaum, 1977.
32. Felson DT, Anderson JJ, Boom M et al. The American-college-of-rheumatology preliminary core set of disease-activity measures for rheumatoid-arthritis clinical-trials. Arthritis Rheum 1993;36:729-40.
33. Tugwell P, Boers M. Orneract conference on outcome measures in rheumatoid-arthritis clinical-trials - introduction. J Rheumatol 1993;20:628-30.